Charleston Oncology ( Site 0019) — Charleston, South Carolina

Charleston Oncology ( Site 0019) is a clinical research site located in Charleston, South Carolina, United States 29414.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Charleston Oncology ( Site 0019) has participated in 1 clinical trials.

Therapeutic areas: Metastatic Non-Small Cell Lung Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charleston Oncology ( Site 0019)?

Charleston Oncology ( Site 0019) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charleston Oncology ( Site 0019) conducted?

Charleston Oncology ( Site 0019) has 1 clinical trials on record. Their work covers Metastatic Non-Small Cell Lung Cancer.

Is Charleston Oncology ( Site 0019) accredited by Crixeo Health?

Charleston Oncology ( Site 0019) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charleston Oncology ( Site 0019)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.